BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 36497260)

  • 1. STIL Promotes Tumorigenesis of Bladder Cancer by Activating PI3K/AKT/mTOR Signaling Pathway and Targeting C-Myc.
    Yu H; Chen L; Wang X; Tang F; Wan Z; Wang H; Fu Q; Chen Z; Shi J; Hu X; Zuhaer Y; Aersi M; Liu T; Tao H; Peng J
    Cancers (Basel); 2022 Nov; 14(23):. PubMed ID: 36497260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Knockdown of STIL suppresses the progression of gastric cancer by down-regulating the IGF-1/PI3K/AKT pathway.
    Wang J; Zhang Y; Dou Z; Jiang H; Wang Y; Gao X; Xin X
    J Cell Mol Med; 2019 Aug; 23(8):5566-5575. PubMed ID: 31187582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The human oncogene SCL/TAL1 interrupting locus (STIL) promotes tumor growth through MAPK/ERK, PI3K/Akt and AMPK pathways in prostate cancer.
    Wu X; Xiao Y; Yan W; Ji Z; Zheng G
    Gene; 2019 Feb; 686():220-227. PubMed ID: 30453068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MRPL13 Promotes Tumor Cell Proliferation, Migration and EMT Process in Breast Cancer Through the PI3K-AKT-mTOR Pathway.
    Cai M; Li H; Chen R; Zhou X
    Cancer Manag Res; 2021; 13():2009-2024. PubMed ID: 33658859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hsa_circ_0023984 Regulates Cell Proliferation, Migration, and Invasion in Esophageal Squamous Cancer via Regulating miR-1294/PI3K/Akt/c-Myc Pathway.
    Liang W; Wang C; Wang J; Zhang M
    Appl Biochem Biotechnol; 2022 Sep; 194(9):1-16. PubMed ID: 35522362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. STIL/AURKA axis promotes cell proliferation by influencing primary cilia formation in bladder cancer.
    Li J; Qi Y; Li B; Liu Y; Yang K; Zhang Z; Zhu J; Du E
    J Transl Med; 2023 Apr; 21(1):281. PubMed ID: 37101292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The human oncogene SCL/TAL1 interrupting locus is required for mammalian dopaminergic cell proliferation through the Sonic hedgehog pathway.
    Carr AL; Sun L; Lee E; Li P; Antonacci C; Gorbea E; Finlay C; Li L
    Cell Signal; 2014 Feb; 26(2):306-12. PubMed ID: 24240054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ARHGAP9 inhibits colorectal cancer cell proliferation, invasion and EMT via targeting PI3K/AKT/mTOR signaling pathway.
    Sun J; Zhao X; Jiang H; Yang T; Li D; Yang X; Jia A; Ma Y; Qian Z
    Tissue Cell; 2022 Aug; 77():101817. PubMed ID: 35679685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding RNA MEG3 functions as a competing endogenous RNA of miR-93 to regulate bladder cancer progression via PI3K/AKT/mTOR pathway.
    Fan X; Huang H; Ji Z; Mao Q
    Transl Cancer Res; 2020 Mar; 9(3):1678-1688. PubMed ID: 35117516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory role of large intergenic noncoding RNA-ROR on tamoxifen resistance in the endocrine therapy of breast cancer by regulating the PI3K/Akt/mTOR signaling pathway.
    Lu PW; Li L; Wang F; Gu YT
    J Cell Physiol; 2019 Feb; 234(2):1904-1912. PubMed ID: 30145819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Jagged2 progressively increased expression from Stage I to III of Bladder Cancer and Melatonin-mediated downregulation of Notch/Jagged2 suppresses the Bladder Tumorigenesis
    Chen YT; Huang CR; Chang CL; Chiang JY; Luo CW; Chen HH; Yip HK
    Int J Biol Sci; 2020; 16(14):2648-2662. PubMed ID: 32792862
    [No Abstract]   [Full Text] [Related]  

  • 12. UCHL5 Promotes Proliferation and Migration of Bladder Cancer Cells by Activating c-Myc via AKT/mTOR Signaling.
    Cao Y; Yan X; Bai X; Tang F; Si P; Bai C; Tuoheti K; Guo L; Yisha Z; Liu T; Liu T
    Cancers (Basel); 2022 Nov; 14(22):. PubMed ID: 36428630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SPOCK1/SIX1axis promotes breast cancer progression by activating AKT/mTOR signaling.
    Xu M; Zhang X; Zhang S; Piao J; Yang Y; Wang X; Lin Z
    Aging (Albany NY); 2020 Dec; 13(1):1032-1050. PubMed ID: 33293473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel HIF1α-STIL-FOXM1 axis regulates tumor metastasis.
    Wang YW; Chen SC; Gu DL; Yeh YC; Tsai JJ; Yang KT; Jou YS; Chou TY; Tang TK
    J Biomed Sci; 2022 Apr; 29(1):24. PubMed ID: 35365182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hsa_circ_0000069 Knockdown Inhibits Tumorigenesis and Exosomes with Downregulated hsa_circ_0000069 Suppress Malignant Transformation via Inhibition of STIL in Pancreatic Cancer.
    Ye Z; Zhu Z; Xie J; Feng Z; Li Y; Xu X; Li W; Chen W
    Int J Nanomedicine; 2020; 15():9859-9873. PubMed ID: 33324055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. KIFC3 Promotes Proliferation, Migration, and Invasion in Colorectal Cancer
    Liao H; Zhang L; Lu S; Li W; Dong W
    Front Genet; 2022; 13():848926. PubMed ID: 35812733
    [No Abstract]   [Full Text] [Related]  

  • 17. SNHG18 inhibits bladder cancer cell proliferation by increasing p21 transcription through destabilizing c-Myc protein.
    Ke M; Sun N; Lin Z; Zhang P; Hu Y; Wu S; Zheng Z; Lu Y; Jin H
    Cancer Cell Int; 2023 Mar; 23(1):48. PubMed ID: 36927398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiogenin interacts with ribonuclease inhibitor regulating PI3K/AKT/mTOR signaling pathway in bladder cancer cells.
    Peng Y; Li L; Huang M; Duan C; Zhang L; Chen J
    Cell Signal; 2014 Dec; 26(12):2782-92. PubMed ID: 25193113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-immunosuppressive triazole-based small molecule induces anticancer activity against human hormone-refractory prostate cancers: the role in inhibition of PI3K/AKT/mTOR and c-Myc signaling pathways.
    Leu WJ; Swain ShP; Chan SH; Hsu JL; Liu SP; Chan ML; Yu CC; Hsu LC; Chou YL; Chang WL; Hou DR; Guh JH
    Oncotarget; 2016 Nov; 7(47):76995-77009. PubMed ID: 27769069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of PI3K/Akt/mTOR/c-Myc/mtp53 Positive Feedback Loop Induces Cell Cycle Arrest by Dual PI3K/mTOR Inhibitor PQR309 in Endometrial Cancer Cell Lines.
    Hsin IL; Shen HP; Chang HY; Ko JL; Wang PH
    Cells; 2021 Oct; 10(11):. PubMed ID: 34831139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.